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Abstract 
 
Background 
Currently 60% of the United States population is overweight or obese.  Recent data has 
shown that 7% of the US population has Diabetes Mellitus Type 2 and New Mexico is 
above the average at 9%.  Many studies have shown that good glycemic control with 
lifestyle changes or Metformin therapy can prevent or delay microvascular and some 
macrovascular complications of Diabetes.  These findings have not been translated into 
routine care especially in New Mexico in large part due to NMs largely, rural, poor and 
medically underserved population.   The Extension for Community Healthcare Outcomes 
(ECHO) is a project developed at the University of New Mexico Health Science Center 
(UNMHSC) that connects UNMHSC expects with providers in rural New Mexico using a 
tele-health network.  Although the ECHO project was first developed to treat Hepatitis C, 
its design allows it to be replicated for other complex and chronic diseases such as 
Diabetes Mellitus Type 2.  We sought to evaluate the project as a teaching tool for 
medical students participating in rural education programs. We hypothesize that medical 
students participating in the diabetes ECHO project will demonstrate improved 
knowledge and a positive attitude towards the treatment and care for patients with 
diabetes. 
Methods 
A total number of 14 first through fourth year medical students were assigned to either an 
intervention group or control group.  The intervention group completed four to eight 
weeks of the Extension for Community Healthcare Outcomes (ECHO) telehealth 
program on diabetes knowledge and attitude towards treatment while in a healthcare 
rotation in a rural New Mexico community.  The control group completed four to eight 
weeks of a rural New Mexico rotation but did not participate in weekly tele-health 
clinics.  Surveys rating the participant’s knowledge and attitude towards diabetes were 
given before and after the four to eight week clinics.       
Results 
There was at least one question with a significant change between the pre and post survey 
group that participated in the ECHO telehealth clinics in each survey.  Two out of the 
thirty-three questions for the Diabetes Attitude Survey, one out of the seven for the 
Diabetes Knowledge Survey and, one out of the twelve questions for the Attitudes 
Diabetes Care Survey showed a significant change.  There were no significant differences 
between the post survey intervention group compared to the post survey control group 
that did not participated in the ECHO telehealth clinics. 
Conclusions 
Although not statistically significant, the ECHO telehealth program showed improving 
attitudes and knowledge in treatment and understanding of type 2 diabetes mellitus.    
 
Background  
Over the last several years, landmark studies have demonstrated that 1) diabetes can be 
prevented with life style changes or Metformin therapy (1); 2) glycemic control prevents 
or delays microvascular and some macrovascular complications (3,4); and 3) control of 
blood pressure and lipids delays or prevents the onset of micro and macrovascular disease 
(2,5,6).  Unfortunately, these findings have not been translated into routine practice.  This 
void is particularly severe in rural areas because providers are isolated from the 
customary methods of continuing education and consultation.  These barriers include but 
are not limited to: 
1. Lack of specialty care in rural and medically underserved areas. 
2. Lack of resources for patients to travel to see specialists at distant sites. 
3. Limited capacity to empower providers with new knowledge 
4. Limited capacity to overcome provider’s attitudes and beliefs regarding 
preventive initiatives.  
5. High provider/patient ratios 
6. High provider turnover 
7. Patient beliefs 
8. Overwhelming abundance of prevention guidelines for prevalent disease 
processes 
9. Cost of health care 
  
 New Mexico (NM) is particularly susceptible to the inability to transfer new 
knowledge to prevent and treat diabetes, diabetic complications, and cardiovascular 
disease. NM is a largely rural and medically underserved state. NM has an area of 
122,000 square miles but only 3 metropolitan areas with >100,000 residents and only one 
academic medical center, The University of New Mexico HSC. Over half of NM’s 1.83 
million residents are made up of minorities (44.7% non-Hispanic white, 42.1% Hispanic, 
and 9.5% Native Americans, and 3.7% other).  NM’s poverty rate (17.7%) led the nation 
in both 2000 and 2001 (national average 11.7%).  Of the states 33 counties, 32 have been 
designated as Medically Underserved Areas (MUA’s) by the Department of Health and 
Human Services (DHHS).  In addition, 14 counties are designated as Health Professional 
Shortage Areas (HPSAs) for primary care physicians.  Only 20% of NM’s licensed 
physicians practice outside of urban areas and very few of them specialize in complex 
diseases (14). Because minorities are at greater risk for diabetes, NM has a higher 
prevalence of diabetes compared to other states (9% compared to the national average of 
6%) (15). The fragmented health care system, lack of resources, rural demographics, 
provider shortages, large minority populations, high rates of medically uninsured patients 
and poverty all contribute to poorer outcomes for diabetic patients in NM than elsewhere.  
As a result, developing more effective methods for delivering diabetes care to medically 
underserved areas should be one of state’s highest priorities. 
 Previous attempts to improve care in rural and medically underserved areas have 
met with limited success.  For example, Kirkman et al devised a multifaceted intervention 
targeting primary care providers, patients, and the health care system of a rural county in 
Indiana (9).  The local physicians devised guidelines for treatment of diabetes based on 
consensus; providers were given information about their overall performance based on 
the guidelines multiple times throughout the study.  Practice aids were developed and 
distributed to providers, chart flow sheets were devised and implemented, and extensive 
patient and physician education sessions were held.  Multiple outcomes were measured.  
At the end of the first year of the study there were significant improvements in the 
number of blood pressure measurements taken, referrals for annual eye examination, 
annual foot examinations, and the number of HbA1C measurements done per year.  
However, by the end of the second year, despite ongoing intervention, only the number of 
blood pressure measurements and annual foot exams remained improved over baseline.  
Additionally, despite more testing there were no improvements in blood pressure or 
HbA1C.   
 Interventions that have demonstrated some success in improving implementation of 
diabetes guidelines have occurred in closed systems, including VAMCs and managed 
care organizations.  These systems are unique in that they have multiple tiers of checks 
and balances in place to keep providers on target.  Unfortunately, rural and medically 
underserved areas are not afforded similar resources as are available in managed care 
systems (15,16).  
  The University of New Mexico (UNM HSC) has recently developed a widely 
applicable model for providing specialty level care to patients with chronic, common and 
complex diseases who do not have direct access to specialists. This project entitled, 
“Project ECHO – Extension for Community Healthcare Outcomes”, connects UNMHSC 
experts with rural providers using a tele-health network. Tele-health clinics are held 
weekly. Multiple providers are connected simultaneously and present real patients. The 
patients are co-managed by the rural providers and the UNMHSC specialist.  The model 
utilizes case-based learning and evidence based disease management while 
simultaneously co-managing patients. The weekly telemedicine clinics serve as a 
“knowledge network”. Community providers in the network learn best practices in 
chronic disease management through “learning loops,” in which they co-manage diverse 
patients with the UNMHSC specialist while expanding their knowledge.  Over time, 
these learning loops create deep knowledge, skills and comfort in offering state-of-the-art 
care in rural areas. Rural providers become champions or regional experts in specific 
chronic diseases thus increasing patient access to specialty level care.  
Project ECHO was initiated in 2004 to treat Hepatitis C (HCV) infected patients in rural 
and medically undeserved communities of NM.  
 The design of the ECHO model allows it to be replicated for other complex and 
chronic diseases. Since the model was first tested for HCV, it appears to be robust 
enough to deliver best practices on many health conditions. ECHO can thus serve as a 
platform that is able to deliver and evaluate best practices for priority populations in rural 
and other underserved areas, not just those who live in close proximity to a large medical 
center.  The purpose of this proposal is to design and implement the ECHO model in the 
prevention of diabetes and diabetic complications including cardiovascular disease in 
rural New Mexico.  This proposal is based upon the premise that poor outcomes in 
diabetes prevention and treatment are at least partly due to providers’ lack of knowledge 
about cost-effective treatment, misplaced priorities, inertia, or lack of provider 
confidence.  Project ECHO represents a novel method for not only improving provider 
skills in diabetes and cardiovascular disease but also for changing their attitudes about 
aggressive treatment.   
 The University of New Mexico School of medicine is internationally recognized 
for its innovating problem based learning curriculum as well as its rural medicine training 
and outreach.  The ECHO model may represent an novel method to improve medical 
student education while on rural rotations.  Our hypothesis states that students 
participating in the diabetes ECHO project will demonstrate not only improved 
knowledge of the treatment of patients with diabetes but will also demonstrate a more 
positive attitude toward the care of patients with diabetes.  The aims of this study were to 
assess the capability of the ECHO model to increase medical student knowledge on 
current best practices of care for the treatment of diabetes and diabetes complications and 
to assess the capability of the ECHO model to improve medical student attitudes toward 
treating patients with diabetes.   
 
Methods 
We conducted a study involving medical students at the University of New Mexico who 
were surveyed on their attitude toward and knowledge of Diabetes Mellitus Type 2 
before and after a four to eight week telehealth program modeled after the Hepatitis C 
ECHO program.  There were two groups including an intervention group of seven 
students that participated in the weekly telehealth program and a control group of nine 
students who did not participate in the weekly clinics.     
Participants 
Eligibility criteria included medical students of all four years at the University of New 
Mexico who participated in a rural community rotation in New Mexico for a duration of 
four weeks or more.  Students were excluded if they participated in a rotation that was 
not considered a rural community of New Mexico.   
Analytical Methods 
Eligible participants were assigned to either the intervention group or the control group 
depending on which group they chose to be a part of.  Those in the intervention group 
were given a survey at the beginning (pre) of their rural rotation and then the exact same 
survey at the end (post) of the four to eight week telehealth program.  There were three 
different surveys.  The first was a diabetes attitude survey which included questions 
asking to rate the participants attitude on diagnosis, prognosis, and treatment of Diabetes 
Mellitus Type 2.  The second was a diabetes care survey which asked the participant to 
compare the difficulty of treating DM Type 2 compared with other chronic conditions 
such as hypertension and asthma.  The third was a diabetes knowledge survey.  Each 
participant in the intervention group connected to the ECHO telehealth clinic weekly 
during their clerkship.  Students presented one patient per session using a standardized 
format.  Cases were discussed and treatment plans were devised by the ECHO team and 
the participating students.   
Statistical Analysis 
Pre and post surveys of the intervention group were compared using paired t-tests for 
each of the three surveys to analyze any significance before and after the ECHO 
telehealth conference program.  Unpaired t-tests were used to analyze data between the 
post survey intervention group and the post survey control group for each of the three 
surveys.  A p value of <0.05 was considered significant for both paired and unpaired t-
tests.       
 
 
 
Results 
Adherence 
All participants completed at least four weeks of the telehealth clinics.  If a student did 
not have a specific patient to present that week they were able to listen to other 
participants presenting a patient problem and the treatment.   
 
Diabetes Attitude Survey Outcomes 
There were two questions with significant improvements between the pre and post 
intervention group for the Diabetes Attitude Survey (Table 1).  The p values were 0.008 
and 0.03 for question numbers 6 and 23 respectively.  Although not statistically 
significant, there were improvements in many other survey questions3from pre to post 
survey (1, 2, 6, 16, 18, 20, 23, 25, 31, 33).  There were no significant differences in the 
post intervention group for Diabetes Attitude Survey compared to the post control group 
for Diabetes Attitude Survey (Table 2).   
 
Table 1. Pre and post survey data of the interventional group for the Diabetes Attitude 
Survey.  The table includes the pretest and posttest mean, the mean difference with a (-) 
number meaning a move towards agreement and a (+) number meaning move towards 
disagreement, and the p value comparing pre and post surveys.   
Question # Pretest mean Posttest mean Mean Difference 
(post – pre) 
p value of difference
1 1.4 1.0 -0.4 0.07 
2 3.9 4.3 0.4 0.07 
3 4.7 4.7 0 1.0 
4 1.6 1.7 0.1 0.6 
5 2.3 2.7 0.4 0.4 
6 1.9 1.1 -0.7 0.008 
7 4.7 4.7 0 1.0 
8 1.7 1.4 -0.3 0.17 
9 1.1 1.0 -0.1 0.35 
10 1.4 1.3 -0.1 0.35 
11 4.4 4.4 0 1.0 
12 1.7 1.6 -0.1 0.6 
13 4.3 4.4 0.1 0.6 
14 2.7 2.7 0 1.0 
15 4.7 4.9 0.1 0.35 
16 3.6 4.1 0.6 0.1 
17 1.4 1.3 -0.1 0.35 
18 1.7 1.3 -0.4 0.07 
19 1.9 1.7 -0.1 0.35 
20 1.7 1.4 -0.3 0.17 
21 1.1 1.0 -0.1 0.35 
22 1.6 1.6 0 1.0 
23 4.3 4.9 0.6 0.03 
24 1.3 1.7 0.4 0.28 
25 2.7 1.7 -1.0 0.13 
26 4.0 3.9 -0.1 0.6 
27 1.6 1.7 0.1 0.6 
28 4.6 4.7 0.1 0.6 
29 2.1 1.9 -0.3 0.17 
30 2.0 1.9 -0.1 0.35 
31 2.3 1.4 -0.9 0.07 
32 2.0 1.9 -0.1 0.35 
33 1.1 1.4 0.3 0.17 
 
Table 2. Post survey of the interventional group and post survey of the control group for 
the Diabetes Attitude Survey.  The table includes the intervention post survey and control 
post survey mean, intervention and control post survey standard deviation, and the p 
value comparing intervention post and control post surveys.    
Question 
#  
intervention post 
mean 
control post 
mean 
intervention post 
std dev 
control post 
std dev 
p 
value 
1 1 1.8 0 1.3 0.14 
2 4.2 4.2 0.76 0.44 0.84 
3 4.7 4.6 0.49 1.33 0.77 
4 1.7 1.6 0.76 1.01 0.73 
5 2.7 2.1 0.95 0.6 0.14 
6 1.1 1.3 0.37 0.5 0.42 
7 4.7 4.8 0.49 0.44 0.79 
8 1.4 1.6 0.53 1.01 0.77 
9 1 1.2 0 0.44 0.21 
10 1.3 1.4 0.49 0.72 0.63 
11 4.4 4.1 0.53 0.6 0.29 
12 1.6 1.8 0.53 0.97 0.62 
13 4.4 4.6 0.53 0.53 0.64 
14 2.7 2.7 0.95 1.1 0.93 
15 4.9 4.4 0.37 1.3 0.44 
16 4.1 4.1 0.69 0.6 0.92 
17 1.3 1.2 0.49 0.44 0.79 
18 1.3 1.8 0.49 0.67 0.12 
19 1.7 1.6 0.76 0.74 0.82 
20 1.4 1.6 0.53 0.72 0.7 
21 1 1.2 0 0.44 0.21 
22 1.6 1.9 0.79 0.78 0.44 
23 4.9 4.7 0.38 0.5 0.42 
24 1.7 1.4 0.76 0.73 0.48 
25 1.7 1.7 0.76 1 0.92 
26 3.9 4.2 0.69 1.09 0.46 
27 1.7 1.6 0.76 0.73 0.68 
28 4.7 4.8 0.49 0.44 0.79 
29 1.9 1.7 0.69 0.7 0.59 
30 1.9 1.9 0.69 0.78 0.93 
31 1.4 1.6 0.53 0.52 0.64 
32 1.9 2.3 0.69 0.70 0.19 
33 1.4 1.3 0.53 0.5 0.72 
 
 
Diabetes Knowledge Survey Outcomes 
There was one question that had a significant change between the pre and post 
interventions group for the Diabetes Knowledge Survey (Table 3).  Question number 7 
had a p value of 0.04 and a mean difference of -0.9.  There were no significant 
differences in the post intervention group for the Diabetes Knowledge Survey compared 
to the post control group for the Diabetes Knowledge Survey (Table 4). 
 
Table 3. Pre and post survey data of the interventional group for the Diabetes Knowledge 
Survey.  The table includes pretest and posttest mean, the mean difference with a (-) 
number meaning a move towards agreement and a (+) number meaning move towards 
disagreement, and the p value comparing pre and post surveys.   
Question # Pretest mean Posttest mean Mean Difference 
(post – pre) 
p value of difference
1 4.3 4.3 0 1.0 
2 1.7 1.7 0 1.0 
3 1.3 1.0 -0.3 0.35 
4 3.0 2.9 -0.1 0.85 
5 3.4 4.6 1.1 0.12 
6 3.6 4.0 0.4 0.28 
7 2.7 1.9 -0.9 0.04 
 
Table 4. Post survey of the interventional group and post survey of the control group for 
the Diabetes Knowledge Survey.  The table includes the intervention post survey and 
control post survey mean, intervention and control post survey standard deviation, and 
the p value comparing intervention post and control post surveys.    
Question 
# 
intervention post 
mean 
control post 
mean 
intervention post 
std dev 
control post 
std dev 
p 
value 
1 4.3 4.4 0.76 0.52 0.62 
2 1.7 2.4 0.48 1.51 0.24 
3 1 1.1 0 0.33 0.39 
4 2.9 2.8 1.78 1.48 0.92 
5 4.6 3.7 0.53 1.22 0.09 
6 4.0 3.6 1 1.23 0.45 
7 1.9 2.1 0.89 0.73 0.47 
 
 
 
Attitude Diabetes Care Survey Outcomes 
There was one significant change from the post survey intervention group compared to 
the post survey intervention group for the Attitudes Diabetes Care Survey (Table 5).  
Question number 11 had a p value of 0.008 and a mean difference of -1.5.  There were no 
significant changes in the post survey intervention compared to the post survey control 
group for the Attitudes Diabetes Care Survey (Table 6). 
 
Table 5. Pre and post survey data of the interventional group for the Attitudes Diabetes 
Care Survey.  The table includes pretest and posttest mean, the mean difference with a (-) 
number meaning a move towards agreement and a (+) number meaning move towards 
disagreement, and the p value comparing pre and post surveys.   
Question # Pretest mean Posttest mean Mean difference
(post – pre) 
p value of difference 
1 5.4 5.6 0.1 0.91 
2 5.7 5.4 -0.3 0.68 
3 5.6 6.1 0.6 0.41 
4 5.1 4.6 -0.6 0.17 
5 5.7 5.4 -0.3 0.6 
6 6.1 5.1 -1.0 0.35 
7 4.7 4.4 -0.3 0.82 
8 4.3 4.7 0.4 0.53 
9 6.4 5.7 -0.7 0.61 
10 2.3 1.4 -0.9 0.07 
11 5.9 4.4 -1.5 0.008 
12 5.4 5.1 -0.3 0.71 
 
 
Table 6. Post survey of the interventional group and post survey of the control group for 
the Attitudes Diabetes Care Survey.  The table includes the intervention post survey and 
control post survey mean, intervention and control post survey standard deviation, and 
the p value comparing intervention post and control post surveys.    
Question 
# 
intervention post 
mean 
control post 
mean 
intervention post 
std dev 
control post 
std dev 
p 
value 
1 5.6 5.1 1.17 2.42 0.68 
2 5.4 5.0 0.97 2.18 0.66 
3 6.1 5.1 0.44 2.89 0.37 
4 4.6 5.4 0.62 1.51 0.20 
5 5.4 4.8 0.97 1.54 0.49 
6 5.1 4.3 1.31 1.77 0.45 
7 4.4 4.4 1.43 1.51 0.99 
8 4.7 5.6 0.96 2.13 0.39 
9 5.7 5.8 1.33 2.28 0.95 
10 1.4 2.3 0.51 1.58 0.19 
11 4.4 4.2 0.90 2.17 0.83 
12 5.1 5.7 0.94 1.58 0.51 
 
 
 
Discussion 
 
Diabetes Attitude Survey 
 There were two significant changes in the Diabetes Attitude Survey in the group 
that participated in the ECHO telehealth clinics.  The first significant change was 
question six which asked the participant to rate from 1 (strongly agree) to 5 (strongly 
disagree) whether or not health care professionals should be taught how daily diabetes 
care affect’s patients lives.  The pretest mean was 1.9 and posttest mean was 1.1 with a 
significant p value of 0.008 (table 1).  The participants went from an average answer of 
agree to an average answer or strongly agree.  This is an interesting question as it asks the 
participant to think about how the patient’s social life is affected by his/her disease.  It is 
hard to teach physiology, anatomy, and pathophysiology in four years of medical school 
for every organ system let alone teaching the student to ask patient’s how their disease is 
affecting their personal life.  This study has shown that the ECHO project has touched on 
this topic and how important it is for providers to be educated not only on the physical 
aspects of a disease but how it may affect the patient socially.   
 The second significant question was question number twenty three which asked 
participants to rate from 1 to 5 if people who have type 2 diabetes will probably not get 
much payoff from tight control of their blood sugars.  The pretest mean was 4.3 and the 
posttest mean was 4.9 with a significant p value of 0.03 (table 1).  The average answer 
went from disagree to strongly disagree.  This question reflects the challenges of type 2 
diabetes treatment.  This study has impacted the participants by teaching that proper 
treatment and therefore tight glycemic control will actually benefit the patient.  Although 
there were only two significant changes in the Diabetes Attitude Survey, all thirty three 
questions showed a move in the direction of a more positive attitude towards diabetes and 
a better understanding of care (see Table 1 and Appendix 1 for additional information). 
 There were no significant differences between the post intervention group and the 
post control group for the Diabetes Attitude Survey (table 2).  This could be due to the 
fact that we had a smaller number of participants in the intervention group compared to 
the control group.  It could also mean that medical students at the University of New 
Mexico gain a more positive attitude and better patient care towards diabetes during their 
rural rotation regardless of any interventions.  This is hard to establish because a pre 
control survey was not conducted to compare those students before and after their rural 
rotation who did not participate in the weekly ECHO telehealth clinics.   
 
Diabetes Knowledge Survey 
 The pre and post intervention group for the Diabetes Knowledge Survey showed 
one significant change.  Participants in this survey rated their knowledge on type 2 
diabetes treatments and disease processes by answering 1 (agree) to 5 (disagree).  
Question seven asked the participant whether insulin sensitizing agents offer significant 
advantages to patients with type 2 diabetes when used alone or in combination with 
sulfonylureas or insulin.  The pretest mean was 2.7 and the posttest mean was 1.9 with a 
significant p value of 0.04 (table 3).  This shows that the participants knowledge moved 
from somewhat agree more towards agree.  The treatment of type 2 diabetes is very 
complex with many different medications and combinations.  It is very reassuring that the 
medical students in this study learned significantly more than they knew before.  This 
knowledge can be taken back to other physicians in rural areas for better patient care.  
 Like the Diabetes Attitude Survey, all other questions showed a move towards 
better knowledge of diabetes treatments and disease processes.  There were no significant 
differences between the post intervention group and the post control group for the 
Diabetes Knowledge Survey (table 4).  This again may be due to the fact that there was 
smaller number or participants in the intervention group compared to the control group.   
   
Attitudes Diabetes Care Survey 
 This survey was composed of two different parts.  The first nine questions asked 
participants to rate the difficulty of treating diabetes compared to other chronic conditions 
such as hypertension or back pain.  The participants rated the difficulty from 1 (easier) to 
8 (harder).  The last three questions asked the participant to rate again from 1 (strongly 
agree) to 8 (strongly disagree) on whether treatment is efficacious, the participant is 
confident in their own abilities, and if there is enough time and resources.  There was one 
significant change in the pre and post intervention group.  Question eleven had a pretest 
mean of 5.9 and a post test mean of 4.4 with a significant p value of 0.008 (table 5).  This 
question asked participants to rate how confident they are in their own abilities in treating 
type 2 diabetes.  This indicates that the ECHO telehealth program helped produce 
confidence in the treatment of diabetes through its education.   
 This survey also shows that medical students in both the intervention group and 
the control group on average believe that diabetes is harder to treat than other chronic 
conditions (tables 5 & 6).  This indicates that the aim of the ECHO project to teach 
students on achieving better understanding of type 2 diabetes treatment is a much needed 
service.   
 There were no significant differences between the post intervention group and 
post control group for the Attitudes Diabetes Care Survey (table 6).  The posttest means 
for both groups were relatively similar indicating that the clinics did not have much 
impact on how students felt about comparing how hard the treatment of diabetes is to 
other chronic conditions.   
 
Limitations 
 There were a few limitations in this study that if were relieved may have had a 
more positive outlook for the ECHO telehealth project.  First the study did not have the 
power that we originally had planned on.  Each group should have had ten participants 
which fell short.  Recruitment for the study was hard as medical students have a very 
busy schedule and may not want to take on another project. 
 A second limitation is that we failed to give pre surveys to the control group.  The 
pre and post surveys could have been compared to see if there were any significant 
changes.  This would have helped us to draw a conclusion to whether the rural rotation 
itself or the ECHO telehealth clinics had an impact on studentsstudent’s attitudes and 
knowledge for type 2 diabetes.   
 Finally we did not take in to consideration which year each medical student was 
currently in.  The control group may have been made up of third and fourth years while 
the intervention group may have been mostly first years.  In this case, the control group 
would by experience have more knowledge of diabetes than the preclinical first years 
therefore skewing the results. 
 
Conclusion 
 In conclusion, our study showed that although not all significant, the attitudes and 
knowledge of type 2 diabetes moved towards a more positive and informative view in 
medical students at the University of New Mexico.  As this is a pilot study, many aspects 
of the project can now be modified for future research.    
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Appendix I 
 
Diabetes Attitude Survey 
 
Below are some statements about diabetes.  Each numbered statement finishes the sentence “In 
general, I believe that...”  You may believe that a statement is true for one person but not for 
another person or may be true one time but not be true another time.  Mark the answer that you 
believe is true most of the time or is true for most people.  Place a check mark in the box below the 
word or phrase that is closest to your opinion about each statement.  It is important that you answer 
every statement. 
 
Note: The term “health care professionals” in this survey refers to doctors, nurses, and dietitians. 
 
 Strongly    Strongly 
 Agree Agree Neutral Disagree Disagree 
In general, I believe that: 
 
1. ...health care professionals who  
 treat people with diabetes should  
 be trained to communicate well  
 with their patients.      
 
2. ...people who do not need to take  
 insulin to treat their diabetes have 
 a pretty mild disease.      
 
3. ...there is not much use in trying to  
 have good blood sugar control 
 because the complications of  
 diabetes will happen anyway.      
 
4. ...diabetes affects almost every  
 part of a diabetic person’s life.      
 
5. ...the important decisions regarding 
 daily diabetes care should be made 
 by the person with diabetes.      
 
6. ...health care professionals should 
 be taught how daily diabetes care 
 affects patients’ lives.      
 
                                                                                Strongly    Strongly 
 Agree Agree Neutral Disagree Disagree 
In general, I believe that: 
 
7. ...older people with Type 2*  
 diabetes do not usually get  
 complications.      
 
8. ...keeping the blood sugar close to 
 normal can help to prevent the 
 complications of diabetes.      
 
9. ...health care professionals should  
 help patients make informed  
 choices about their care plans.      
 
10. ...it is important for the nurses 
 and dietitians who teach people  
 with diabetes to learn  
 counseling skills.      
 
11. ...people whose diabetes is treated 
 by just a diet do not have to worry 
 about getting many long-term 
 complications.      
 
12. ...almost everyone with diabetes  
 should do whatever it takes to keep 
 their blood sugar close to normal.      
 
13. ...the emotional effects of diabetes 
 are pretty small.      
 
 
 
 
* Type 2 diabetes usually begins after age 40.  Many patients are overweight and weight loss is often an 
important part of the treatment.  Insulin and/or diabetes pills are sometimes used in the treatment.  
Type 2 diabetes is also called noninsulin-dependent diabetes mellitus or NIDDM; formerly it was 
called “adult diabetes.” 
                                                                                Strongly    Strongly 
 Agree Agree Neutral Disagree Disagree 
 
In general, I believe that: 
 
14. ...people with diabetes should  
 have the final say in setting their  
 blood glucose goals.      
 
15. ...blood sugar testing is not needed 
 for people with Type 2* diabetes.      
 
16. ...low blood sugar reactions make 
 tight control too risky for most 
 people.      
 
17. ...health care professionals should 
 learn how to set goals with patients, 
 not just tell them what to do.      
 
18. ...diabetes is hard because you 
 never get a break from it.      
 
19. ...the person with diabetes is the  
 most important member of the  
 diabetes care team.      
 
20. ...to do a good job, diabetes  
 educators should learn a lot about  
 being teachers      
 
21. ...Type 2* diabetes is a very 
 serious disease.      
 
22. ...having diabetes changes a  
 person’s outlook on life.      
 
 
* Type 2 diabetes usually begins after age 40.  Many patients are overweight and weight loss is 
often an important part of the treatment.  Insulin and/or diabetes pills are sometimes used in 
the treatment.  Type 2 diabetes is also called noninsulin-dependent diabetes mellitus or 
NIDDM; formerly it was called “adult diabetes.” 
 
                                                                                Strongly    Strongly 
 Agree Agree Neutral Disagree Disagree 
In general, I believe that: 
 
23. ...people who have Type 2* 
 diabetes will probably not get 
 much payoff from tight control 
 of their blood sugars.      
 
24. ...people with diabetes should 
 learn a lot about the disease so that 
 they can be in charge of their own 
 diabetes care.      
 
25. ...Type 2* is as serious as  
 Type 1† diabetes.     
 
 
26. ...tight control is too much work.      
 
 
27. ...what the patient does has more 
 effect on the outcome of diabetes  
 care than anything a health  
 professional does.      
 
28. ...tight control of blood sugar  
 makes sense only for people   
 with Type 1† diabetes.     
 
* Type 2 diabetes usually begins after age 40.  Many patients are overweight and weight loss is often an 
important part of the treatment.  Insulin and/or diabetes pills are sometimes used in the treatment.  
Type 2 diabetes is also called noninsulin-dependent diabetes mellitus or NIDDM; formerly it was 
called “adult diabetes.” 
 
†Type 1 diabetes usually begins before age 40 and always requires insulin as part of the treatment.  
Patients are usually not overweight.  Type 1 diabetes is also called insulin-dependent diabetes mellitus 
or IDDM; formerly it was called “juvenile diabetes.” 
 
                                                                                Strongly    Strongly 
 Agree Agree Neutral Disagree Disagree 
In general, I believe that: 
 
 
29. ...it is frustrating for people with 
 diabetes to take care of their 
 disease.      
 
30. ...people with diabetes have a right 
 to decide how hard they will work  
 to control their blood sugar.      
 
31. ...people who take diabetes pills 
 should be as concerned about their 
 blood sugar as people who take 
 insulin.      
 
32. ...people with diabetes have the  
 right not to take good care of their 
 diabetes.      
 
33. ...support from family and friends 
 is important in dealing with 
 diabetes.     
Appendix I cont. 
 
Attitudes Diabetes Care 21:1391-1396, 1998. Larme et al 
 
Compare the difficulty of treatment of     
diabetes with these other chronic conditions.  1=easier  8= harder 
 
 Hypertension    1 2 3 4 5 6 7 8 
 Arthritis  1 2 3 4 5 6 7 8 
 Cholesterol  1 2 3 4 5 6 7 8 
 Depression  1 2 3 4 5 6 7 8 
 Asthma  1 2 3 4 5 6 7 8 
 Headache  1 2 3 4 5 6 7 8 
 Back pain  1 2 3 4 5 6 7 8 
 Heart Failure  1 2 3 4 5 6 7 8 
 Peptic Ulcer Disease  1 2 3 4 5 6 7 8 
 
 
Please rate the following  
your beliefs about diabetes 
treatment.    1=strongly agree 8= strongly disagree 
 
Treatment is efficacious 1 2 3 4 5 6 7 8 
Confident in own abilities 1 2 3 4 5 6 7 8 
Enough time and resources 1 2 3 4 5 6 7 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix II 
 
Knowledge/attitude survey Diabetes care 22:19280-1932, 1999.   
 
agree agree somewhat   neutral disagree somewhat  disagree 
 
   1   2      3   4        5 
 
  
1. All oral agents used to treat diabetes    
are equally effective.     1 2 3 4 5  
 
2. Diabetes is a progressive disease that 
requires increasing numbers of therapies 
or doses of agents to control it over time.  1 2 3 4 5  
 
3. It is important for patients with type 2  
diabetes to maintain a HbA1c<7 %.  1 2 3 4 5  
 
4. Patients with insulin resistance do not  
frank diabetes.     1 2 3 4 5  
 
5. As diabetic patients get older, it is better 
 for them to have higher glucose levels, 
 mimicking normal aging process.  1 2 3 4 5  
 
6. The progressive worsening of diabetes  
as one ages cannot be avoided.   1 2 3 4 5  
 
7. Insulin sensitizing oral agents offer  
significant advantages to patients with  
type 2 diabetes when used alone or in  
combination with sulfonylureas or insulin. 1 2 3 4 5 
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